CLINICAL_TRIALS
trial_result
· 2024-07-19
Clinical Trial Update: Steroid-reducing Effects of Crisaborole [Phase 4]
Summary
Phase 4 trial results indicate crisaborole may have steroid-sparing effects in atopic dermatitis, with results posted on July 19, 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Johns Hopkins University | Conditions: Atopic Dermatitis, Eczema | Phase 4 | Status: COMPLETED | Results posted: 2024-07-19